India, Oct. 29 -- While reporting financial results for the third quarter on Thursday, Bristol-Myers Squibb Co. (BMY) slashed its earnings guidance for the full-year 2026, while raising annual revenue outlook.
For fiscal 2026, the company now projects earnings in a range of about $6.35 to $6.55 per share on worldwide total revenues between about $49.75 billion and $50.25 billion.
The company noted that the guidance includes a $0.60 per share net impact from Acquired IPRD charges and licensing income.
Previously, the company expected earnings in the range of about $6.75 to $7.00 per share on worldwide total revenues between about $49.0 billion and $50.0 billion.
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568189509843-...